APOE and hyperlipidemia: Plasma apoE protein concentrations have been reported to be higher in T2DM patients than in healthy controls (Franczyk et al., 2023), and plasma cholesterol ester transport protein (CETP) amounts are reportedly higher in hyperlipidemia individuals and considered atherogenic (McPherson et al, 1991).